Aqua Bio Technology ASA - Results for first half year 2024

23 Aug 2024 22:30 CEST

23.8.2024 22:30:48 CEST | Aqua Bio Technology ASA | Half yearly financial
reports and audit reports / limited reviews

* Agreement in principle to acquire Jetcarrier AS, a major international
warehouse and logistic group.
* Agreement in principle acquisition of 3D Innovation Nordic AS and affiliated
companies, together a potential major wholesale group in the Nordics.
* Cosmed Beauty AS buyout and named new CFO for the ABT group Jan Varming.
* Entered into agreement for the acquisition of Ovalen AS (Pusterom Hudpleie)
and completed the acquisition.
* Private placement sucessfully placed.
* Due to the Group's increased activity ABT started with quarterly reports to
the market.


The company's revenues in the first half of 2024 were NOK 61.1 million versus
NOK 7.2 million in the same period last year.

Cost of goods amounted to NOK 35.4 million in the first half of the year,
compared with NOK 3.2 million in the same period last year. The company's salary
costs and other sales and administration costs (excluding cost of goods) were
NOK 31.8 million in the first half of 2024. In the same period last year, the
costs were NOK 10.7 million. Gross margin for the first half of 2024 was 41%
versus 44% first half of 2023.

EBITDA for the first half of 2024 was NOK - 9.2 million compared with the
corresponding period last year, when EBITDA was NOK 8.4 million. ABT's profit
after tax was NOK - 18.8 million, compared with NOK 4.7 million in the first
half of 2023. The equity ratio at the end of the first half of 2024 was 39%
versus 11.5% after the first half of 2023.

ABT expects that the acquisitions will significantly affect future results. ABT
expects that ABT consolidated will have more than 250 MNOK in turnover on a
12-month rolling basis from August 2024.

For further information, please contact Jan Varming, CFO, telephone +47
90839076.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.



DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18213192/4887/Download%20announce
ment%20as%20PDF.pdf

ABT Halvarsrapport 2024.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18213192/4886/ABT%20Halvarsrappor
t%202024.pdf

More information:
Access the news on Oslo Bors NewsWeb site

626148_ABT Halvarsrapport 2024.pdf
626148_Download announcement as PDF.pdf